ALX Oncology Holdings (ALXO)
US Market

ALX Oncology Holdings (ALXO) Financial Statements


ALX Oncology Holdings Financial Overview

ALX Oncology Holdings's market cap is currently ―. The company's EPS TTM is $-3.194; its P/E ratio is -1.50; ALX Oncology Holdings is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -33.79M$ -29.80M$ -32.45M$ -36.68M$ -33.79M
EBITDA$ -34.86M$ -30.33M$ -32.55M$ -36.59M$ -33.70M
Net Income Common Stockholders$ -34.16M$ -30.18M$ -30.71M$ -35.32M$ -32.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 212.84M$ 227.94M$ 266.21M$ 284.91M$ 313.37M
Total Assets$ 245.93M$ 278.14M$ 306.49M$ 317.69M$ 346.02M
Total Debt$ 9.51M$ 9.45M$ 9.39M$ 6.60M$ 1.07M
Net Debt$ -203.32M$ -218.49M$ -256.82M$ -278.31M$ -312.29M
Total Liabilities$ 33.24M$ 37.75M$ 43.02M$ 30.73M$ 29.70M
Stockholders Equity$ 212.69M$ 240.39M$ 263.46M$ 286.96M$ 316.32M
Cash Flow-
Free Cash Flow$ -33.45M$ -28.51M$ -21.06M$ -31.07M$ -17.25M
Operating Cash Flow$ -31.71M$ -27.82M$ -20.67M$ -30.88M$ -17.00M
Investing Cash Flow$ 6.21M$ 42.30M$ 10.94M$ 13.70M$ -76.13M
Financing Cash Flow$ 343.00K$ -107.00K$ 9.49M$ -136.00K$ 422.00K
Currency in USD

ALX Oncology Holdings Earnings and Revenue History

ALX Oncology Holdings Debt to Assets

ALX Oncology Holdings Cash Flow

ALX Oncology Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis